Author:Ilaria De Giovanni
Events, Cancer
ASCO 2025
Blogs, Rare diseases
Orphan drugs: How to avoid costly stock losses in Europe
Blogs, Rare diseases
How Biotechs can expand in Europe: Out-licensing vs. partnering
Thought Leadership, Rare diseases
Market access for orphan drugs in Switzerland: a guide for US Biotechs
Blogs, Rare diseases
An introduction to PASS studies
Events, Rare diseases
Sciensus hosts a panel at the World Orphan Drug Congress 2024
Thought Leadership, Rare diseases
The impact of real-world data in gaining access to the European orphan drugs market.
Thought Leadership, Rare diseases
Navigating early access in Europe: a strategic blueprint for biotech leaders